Free Trial

Cyclerion Therapeutics (CYCN) SEC Filings & 10K Form

Cyclerion Therapeutics logo
$3.19 +0.24 (+8.14%)
(As of 12/20/2024 05:31 PM ET)

Recent Cyclerion Therapeutics SEC Filings

DateFilerForm TypeView
12/17/2024
7:16 AM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
3:05 PM
Cyclerion Therapeutics (Issuer)
Greenspan David Gerald (Reporting)
Slate Path Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:14 AM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
5:45 AM
Cyclerion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
5:17 PM
Artal International S.C.A. (Filed by)
Cyclerion Therapeutics (Subject)
Form SC 13G/A
04/29/2024
3:18 PM
Cyclerion Therapeutics (Filer)
Form DEF 14A
04/29/2024
3:21 PM
Cyclerion Therapeutics (Filer)
Form DEFA14A
02/09/2024
4:06 PM
Artal International S.C.A. (Filed by)
Cyclerion Therapeutics (Subject)
Form SC 13G/A
02/09/2024
7:50 AM
Cyclerion Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/22/2024
2:44 PM
Cyclerion Therapeutics (Subject)
Slate Path Capital LP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CYCN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners